A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...

Findings show potential for new lipid-based delivery formulations as a platform technology for immunization. Philadelphia, PA, March 21, 2025 (GLOBE NEWSWIRE) -- Scientists in The ...

The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

causing “integration” of contaminated DNA, State Surgeon General Dr. Joseph Ladapo said in a letter to the FDA in 2024. But vaccine makers say these concerns are misinformation ...

The DNA vaccine, owned by private biotechnology company Technovalia, and delivered by Vaxxas’ HD-MAP, generated a significant antibody response in mice against multiple domains of the spike ...

Recently published data generated by researchers at The University of Queensland and Vaxxas shows effective delivery of a nucleic acid-based COVID-19 vaccine in a preclinical animal study ...

Credit: BaLL LunLa / Shutterstock. Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The ...

Generated by researchers at The University of Queensland, led by Associate Professor David Muller, the newly published data is based on research assessing a Vaxxas HD-MAP delivered DNA-based COVID-19 ...

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

Here we show that a heterologous prime-boost vaccination regime of DNA either intramuscularly or epidermally, followed by intradermal recombinant modified vaccinia virus Ankara (MVA), induces high ...